STOCKHOLM, October 31, 2018 /PRNewswire/ -- OxThera AB, a Stockholm-based privately-held biopharmaceutical company and leader in the field of microbiome derived biotherapeutics, today announced a poster presentation showing encouraging Oxabact® efficacy and safety data from the...
from PR Newswire: //https://ift.tt/2qnH8hT
No comments:
Post a Comment